No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
Sector Update: Health Care
CG Oncology Bladder Cancer Treatment to Achieve $4 Billion in Sales by 2037, BofA Says
A Closer Look at 9 Analyst Recommendations For CG Oncology
Express News | CG Oncology Inc : BofA Global Research Initiates Coverage With Buy Rating; Price Objective $65
CG Oncology Price Target Announced at $65.00/Share by B of A Securities